Pacific RxTracts - October 2025

Authors

Pacific RxTracts

Files

Description

Articles:

• The Resurgence of Cardiac Glycosides in Heart Failure
• Wayrilz: New Breakthrough for Persistent or Chronic Immune Thrombocytopenia
• Atrasentan: An Emerging Therapy in IgA Nephropathy
• The Second FDA-Approved MASH Treatment
• New Pharmacist-Driven Calcitonin Protocol Delivers Cost Savings in Hypercalcemia of Malignancy Care
• Baxdrostat Offers Hope for Patients with Resistant Hypertension
• Challenging the Norm: Anticoagulant Discontinuation is Safe Postablation
• Olezarsen: Redefining Triglyceride Control Through APOC3 Inhibition
• Semaglutide and Tirzepatide Linked to Increased Risk of Vision Disorders
• At Last, a Step Forward in Gastric and GEJ
• Tarlatamab: A Breakthrough in Relapsed Small Cell Lung
• Expanded FDA Approval for Darolutamide
• Linvoseltamab: Redefining Multiple Myeloma Therapy
• Beyond Diabetes: Neuroprotective and Cerebrovascular Benefits of GLP-1 Receptor Agonists
• Breakthroughs in Alzheimer’s or Only a Step Forward? Lecanemab and Donanemab

Publication Date

10-1-2025

Volume

23

Issue

1

Pages

9

Publisher

University of the Pacific

City

Stockton, CA

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Recommended Citation

Pacific RxTracts, "Pacific RxTracts - October 2025" (2025). Pacific RxTracts. 10.
https://scholarlycommons.pacific.edu/rx-tracts/10